Table 3.
Univariate analysis of factors associated with DFS (N=36)
| Characteristics | Levels | HR (95% CI for HR) | P-value |
|---|---|---|---|
| Sex | Female | 2.7(1.024, 6.987) | 0.0445* |
| Male | 1.0 | - | |
| Age | >20 | 0.9(0.324, 2.626) | 0.8789 |
| ≤ 20 | 1.0 | - | |
| Stage | Localized | 0.7(0.188, 2.263) | 0.5012 |
| Regional extension | 0.9(0.242, 3.048) | 0.8144 | |
| Distant metastasis | 1.0 | - | |
| AKT-Expression | High | 3.0(0.955, 9.499) | 0.0459 |
| Negative/Low | 1.0 | - | |
| mTOR-Expression | High | 1.4(0.405, 5.163) | 0.5695 |
| Negative/Low | 1.0 | - | |
| ERK-Expression | High | 2.3(0.713, 7.650) | 0.1609 |
| Negative/Low | 1.0 | - | |
| YAP-Expression | High | 0.9(0.295, 2.916) | 0.8969 |
| Negative/Low | 1.0 | - |
*Chi-square test significant at α=0.05.